Pre-counseling Education for Low Literacy Women at Risk of Hereditary Breast and Ovarian Cancer (HBOC): Patient Experiences Using the Cancer Risk Education Intervention Tool (CREdIT)

Joseph, Galen; Beattie, Mary; Lee, Robin; Braithwaite, Dejana; Wilcox, Carolina; Metrikin, Maya; Lamvik, Kate; Luce, Judith
October 2010
Journal of Genetic Counseling;Oct2010, Vol. 19 Issue 5, p447
Academic Journal
The Cancer Risk Education Intervention Tool ( CREdIT) is a computer-based (non-interactive) slide presentation designed to educate low-literacy, and ethnically and racially diverse public hospital patients at risk of Hereditary Breast and Ovarian Cancer (HBOC) about genetics. To qualitatively evaluate participants' experience with and perceptions of a genetic education program as an adjunct to genetic counseling, we conducted direct observations of the intervention, semi-structured in person interviews with 11 women who viewed CREdIT, and post-counseling questionnaires with the two participating genetic counselors. Five themes emerged from the analysis of interviews: (1) genetic counseling and testing for breast/ovarian cancer was a new concept; (2) CREdIT's story format was particularly appealing; (3) changes in participants' perceived risk for breast cancer varied; (4) some misunderstandings about individual risk and heredity persisted after CREdIT and counseling; (5) the context for viewing CREdIT shaped responses to the presentation. Observations demonstrated ways to make the information provided in CREdIT and by genetic counselors more consistent. In a post-session counselor questionnaire, counselors' rating of the patient's preparedness before the session was significantly higher for patients who viewed CREdIT prior to their appointments than for other patients. This novel educational tool fills a gap in HBOC education by tailoring information to women of lower literacy and diverse ethnic/racial backgrounds. The tool was well received by interview participants and counselors alike. Further study is needed to examine the varied effects of CREdIT on risk perception. In addition, the implementation of CREdIT in diverse clinical settings and the cultural adaptation of CREdIT to specific populations reflect important areas for future work.


Related Articles

  • Genetic testing delivers ammo against cancer.  // South Asian Post;9/1/2011, p10 

    The article reports on the significance of Hereditary Breast and Ovarian Cancer syndrome (HBOC) test to identify one's risk for breast and ovarian cancer.

  • Screening for Hereditary Breast Ovarian Syndrome. Kurian, Shiney // Journal of Gynecologic Oncology Nursing;Spring2006, Vol. 16 Issue 2, p35 

    Presents information on the medical screening for hereditary breast ovarian syndrome. Discussion on the high risk of women who tested positive for carrying the breast cancer gene BRCA mutations for developing breast and ovarian cancer; Need for women at risk for hereditary breast ovarian cancer...

  • Five Families Living With Hereditary Breast and Ovarian Cancer Risk. Norris, Joan; Spelic, Stephanie Stockard; Snyder, Carrie; Tinley, Susan // Clinical Journal of Oncology Nursing;Feb2009, Vol. 13 Issue 1, p73 

    This qualitative study explores the communication and decision-making strategies of five families with hereditary breast and ovarian cancer (HBOC) risk.Investigators asked female carriers of BRCA1 and BRCA2 genetic mutations to recall early knowledge and experiences concerning cancer...

  • Risk Assessment and Genetic Counseling for Hereditary Breast and Ovarian Cancer: Recommendations of the National Society of Genetic Counselors. Janice Berliner; Angela Fay // Journal of Genetic Counseling;Jun2007, Vol. 16 Issue 3, p241 

    Abstract  These cancer genetic counseling recommendations describe the medical, psychosocial and ethical implications of identifying at-risk individuals for hereditary breast and ovarian cancer (HBOC) through cancer risk assessment, with or without genetic susceptibility testing....

  • Utilization of BRCA testing in older women with breast and/or ovarian cancer in the state of Texas. Rodriguez, Ana M.; Giordan, Sharon H.; Cooksley, Catherine D. // Texas Public Health Journal;Spring2013, Vol. 65 Issue 2, p30 

    The article presents a research which analyzes genetic tests of BRCA1 and BRCA2 gene mutations in older women with hereditary breast ovarian cancer (HBOC) in Texas. It states that medicare for some with breast and ovarian cancer started in 2000 to assess treatment and family testing options. The...

  • Hereditary breast and ovarian cancer. BARKS, PHYLLIS; GOLDGAR, CONSTANCE // JAAPA: Journal of the American Academy of Physician Assistants (;Mar2012, Vol. 25 Issue 3, p63 

    The article offers information on hereditary breast and ovarian cancer (HBOC). It says that HBOC is an autosomal dominant disorder caused by BRCA1 and BRCA2 gene mutations that occur in all ethnic and racial populations. Furthermore, HBOC is hereditary and its development risks in women...

  • Awareness, Perceptions, and Provider Recommendation Related to Genetic Testing for Hereditary Breast Cancer Risk among At-Risk Hispanic Women: Similarities and Variations by Sub-Ethnicity. Vadaparampil, Susan; McIntyre, Jessica; Quinn, Gwendolyn // Journal of Genetic Counseling;Dec2010, Vol. 19 Issue 6, p618 

    This study explored awareness of risk factors for hereditary breast and ovarian cancer (HBOC), awareness, knowledge and concerns about genetic testing, and preference for how to have genetic testing recommended by a care provider among at-risk Hispanic women. Differences in these factors among...

  • Computers aid genetic decisions.  // Australian Nursing Journal;Sep2004, Vol. 12 Issue 3, p29 

    Provides information on the results of studies published in the "Journal of the American Medical Association" regarding the use of an interactive computer program as an educational method to assist women with high breast cancer risk in Australia. Effectiveness of the program to women with high...


    The Oncology Nursing Society and American Society of Clinical Oncology have identified that genetic testing for Hereditary Breast and Ovarian Cancer Syndrome (HBOCS) is not appropriate for screening of the general population, but is an important tool for cancer prevention and early detection in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics